Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Human Reproduction Année : 2017

Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome

Résumé

Does the use of the serum anti-Müllerian hormone (AMH) assay to replace or complement ultrasound (U/S) affect the diagnosis or phenotypic distribution of polycystic ovary syndrome (PCOS)?

Dates et versions

hal-02314172 , version 1 (11-10-2019)

Identifiants

Citer

Alice Fraissinet, Geoffroy Robin, Pascal Pigny, Tiphaine Lefebvre, Sophie Catteau-Jonard, et al.. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome. Human Reproduction, 2017, 32 (8), pp.1716-1722. ⟨10.1093/humrep/dex239⟩. ⟨hal-02314172⟩
40 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More